Home/Kyron.bio/Dr. Emilia McLaughlin

DE

Dr. Emilia McLaughlin

CEO & Founder

Therapeutic Areas

Oncology Autoimmune Diseases Infectious Diseases

Kyron.bio Pipeline

Drug	Indication	Phase
Platform Development & Preclinical Research	Not Specified (Platform Focus)	Preclinical

Leadership Team at Kyron.bio

Dr. Marina Lochhead

Dr. Caroline Desmurget

SENIOR SCIENTIST

Dr. Damien Toullec

View full Kyron.bio profile